Применение омега-3-полиненасыщенных жирных кислот для лечения и профилактики нарушений сердечного ритма: мы в начале пути


Фомин В.В.

ГБОУ ВПО “Первый МГМУ им. И.М. Сеченова” Минздравсоцразвития РФ, Москва
Обсуждается значение ?3-полиненасыщенных жирных кислот (?3-ПНЖК) в лечении и профилактике нарушений сердечного ритма. Приводятся данные исследований, подтверждающих эффективность ?3-ПНЖК в лечении гипертриглицеридемии, профилактике желудочковых аритмий и фибрилляции предсердий. Показано улучшение долгосрочного прогноза, в т. ч. за счет снижения риска внезапной смерти, у больных, перенесших инфаркт миокарда и получавших терапию ?3-ПНЖК.

Литература


1. Riccioni G, Bucciarelli T, Manchini B, et al. Antioxidant vitamin supplementation in cardiovascular disease. Ann Clin Lab Sci 2007; 37(1):89–95.


2. Lonn E, Yusuf S, Hoogwerf B, et al.; HOPE Study; MICRO-HOPE Study. Effects of vitamin E on cardiovascular and microvascular outcomes in highrisk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy. Diabetes Care 2002;25(11):1919–27.


3. Lonn E, Bosch J, Yusuf S, et al.; HOPE and HOPETOO Trial Investigators. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA2005;293(11):1338–47.


4. De Caterina R, Madonna R, Zucchi R, La Rovere MT. Antiarrhythmic effects of omega-3 fatty acids: from epidemiology to bedside. Am Heart J 2003;146(3):420–30.


5. Gissi-HF Investigators, Tavazzi L, Maggioni AP, Marchioli R, et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet2008;372(9645):1223–30.


6. Finzi AA, Latini R, Barlera S, et al. Effects of n-3 polyunsaturated fatty acids on malignant ventricular arrhythmias in patients with chronic heart failure and implantable cardioverter-defibrillators: A substudy of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Insufficienza Cardiaca (GISSIHF) trial. Am Heart J 2011;161(2):338–43.


7. Bacova B, Radosinska J, Knezl V, et al. Omega-3 fatty acids and atorvastatin suppress ventricular fibrillation inducibility in hypertriglyceridemic rat hearts: implication of intracellular coupling protein, connexin-43. J Physiol Pharmacol2010;61(6):717–23.


8. Viljoen A, Wierzbicki AS. Diagnosis and treatment of severe hypertriglyceridemia. Expert Rev Cardiovasc Ther 2012;10(4):505–14.


9. Pieke B, von Eckardstein A, Gulbahce E, et al. Treatment of hypertriglyceridemia by two diets rich either in unsaturated fatty acids or in carbohydrates: effects on lipoprotein subclasses, lipolytic enzymes, lipid transfer proteins, insulin and leptin. Int J Obes Relat Metab Disord2000;24(10):1286–96.


10. Junker R, Pieke B, Schulte H, et al. Changes in hemostasis during treatment of hypertriglyceridemia with a diet rich in monounsaturated and n-3 polyunsaturated fatty acids in comparison with a low-fat diet. Thromb Res 2001;101(5):355–66.


11. Saravanan P, Davidson NC, Schmidt EB, Calder PC. Cardiovascular effects of marine omega-3 fatty acids. Lancet 2010;376(9740):540–50.


12. Sorice M, Tritto FP, Sordelli C, et al. N-3 polyunsaturated fatty acids reduces post-operative atrial fibrillation incidence in patients undergoing “on-pump” coronary artery bypass graft surgery. Monaldi Arch Chest Dis 2011;76(2):93–8.


13. Nodari S, Triggiani M, Campia U, et al. N-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study. Circulation2011;124(10):1100–06.


14. Kumar S, Sutherland F, Rosso R, et al. Effects of chronic omega-3 polyunsaturated fatty acid supplementation on human atrial electrophysiology. Heart Rhythm 2011;8(4):562–68.


15. Ghio S, Scelsi L, Latini R, et al.; GISSI-HF investigators. Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial. Eur J Heart Fail 2010;12(12):1345–53.


16. Marchioli R, Barzi F, Bomba E, et al.; GISSIPrevenzione Investigators. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione. Circulation2002;105(16):1897–903.


Об авторах / Для корреспонденции


Фомин Виктор Викторович – доктор медицинских наук, профессор кафедры терапии и профболезней медико-профилактического факультета, декан лечебного факультета ГБОУ ВПО “Первый МГМУ им. И.М. Сеченова” Минздравсоцразвития РФ. E-mail: fomin_vic@mail.ru


Похожие статьи


Бионика Медиа